![Yuan Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuan Xu
Direttore/Membro del Consiglio presso
FATE THERAPEUTICS, INC.
Patrimonio netto: 21 239 $ in data 31/07/2026
Profilo
Yuan J.
Xu is currently an Independent Director at Fate Therapeutics, Inc. since 2021 and an Independent Director at Xilio Therapeutics, Inc. since 2022.
Former roles include Chief Executive Officer & Director at Legend Biotech Corp.
from 2018 to 2020, Independent Director at Akero Therapeutics, Inc. from 2021 to 2025, Vice President-Biologics at Gilead Sciences, Inc. from 2014 to 2015, Senior Vice President at Merck & Co., Inc. from 2015 to 2017, and Vice President at Novartis AG from 2008 to 2014.
Education includes a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2026 | 8.669 ( 0,01% ) | 21 239 $ | 31/07/2026 | |
LEGEND BIOTECH CORP. -.--% | 08/06/2020 | 0 ( -.--% ) | - $ | 31/07/2026 |
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Yuan Xu
| Società | Posizione | Inizio |
|---|---|---|
| FATE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/08/2021 |
| XILIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 04/01/2022 |
Precedenti posizioni note di Yuan Xu
| Società | Posizione | Fine |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 09/12/2025 |
| LEGEND BIOTECH CORPORATION | Amministratore Delegato | 01/08/2020 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/08/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/08/2015 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2014 |
Formazione di Yuan Xu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
